410 related articles for article (PubMed ID: 20668491)
1. Phase II drug metabolizing enzymes.
Jancova P; Anzenbacher P; Anzenbacherova E
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2010 Jun; 154(2):103-16. PubMed ID: 20668491
[TBL] [Abstract][Full Text] [Related]
2. [Human drug metabolizing enzymes. II. Conjugation enzymes].
Vereczkey L; Jemnitz K; Gregus Z
Acta Pharm Hung; 1998 Sep; 68(5):284-8. PubMed ID: 9805814
[TBL] [Abstract][Full Text] [Related]
3. Regulation of phase II biotransformation enzymes by steroid hormones.
Kohalmy K; Vrzal R
Curr Drug Metab; 2011 Feb; 12(2):104-23. PubMed ID: 21401512
[TBL] [Abstract][Full Text] [Related]
4. [Toxicogenetics and toxicogenomics. Relevance and application in occupational health].
Schulz T
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2006 Oct; 49(10):1004-10. PubMed ID: 17013775
[TBL] [Abstract][Full Text] [Related]
5. Ontogeny of Human Conjugating Enzymes.
Coughtrie MW
Drug Metab Lett; 2015; 9(2):99-108. PubMed ID: 26031463
[TBL] [Abstract][Full Text] [Related]
6. Xenobiotic-metabolizing enzymes in human lung.
Zhang JY; Wang Y; Prakash C
Curr Drug Metab; 2006 Dec; 7(8):939-48. PubMed ID: 17168693
[TBL] [Abstract][Full Text] [Related]
7. Overview of enzymes of drug metabolism.
Meyer UA
J Pharmacokinet Biopharm; 1996 Oct; 24(5):449-59. PubMed ID: 9131484
[TBL] [Abstract][Full Text] [Related]
8. Metabolism and bioactivation of toxicants in the lung. The in vitro cellular approach.
Castell JV; Donato MT; Gómez-Lechón MJ
Exp Toxicol Pathol; 2005 Jul; 57 Suppl 1():189-204. PubMed ID: 16092727
[TBL] [Abstract][Full Text] [Related]
9. Pharmacogenetics of drug metabolizing enzymes in Brazilian populations.
Cerda A; Hirata MH; Hirata RD
Drug Metabol Drug Interact; 2014; 29(3):153-77. PubMed ID: 24744305
[TBL] [Abstract][Full Text] [Related]
10. Going Beyond Common Drug Metabolizing Enzymes: Case Studies of Biotransformation Involving Aldehyde Oxidase, γ-Glutamyl Transpeptidase, Cathepsin B, Flavin-Containing Monooxygenase, and ADP-Ribosyltransferase.
Fan PW; Zhang D; Halladay JS; Driscoll JP; Khojasteh SC
Drug Metab Dispos; 2016 Aug; 44(8):1253-61. PubMed ID: 27117704
[TBL] [Abstract][Full Text] [Related]
11. Mammary expression of xenobiotic metabolizing enzymes and their potential role in breast cancer.
Williams JA; Phillips DH
Cancer Res; 2000 Sep; 60(17):4667-77. PubMed ID: 10987265
[TBL] [Abstract][Full Text] [Related]
12. Co-regulation of expression of phase II metabolizing enzymes and multidrug resistance-associated protein 2.
Catania VA; Sánchez Pozzi EJ; Luquita MG; Ruiz ML; Villanueva SS; Jones B; Mottino AD
Ann Hepatol; 2004; 3(1):11-7. PubMed ID: 15118574
[TBL] [Abstract][Full Text] [Related]
13. Pharmacogenetics of drug-metabolizing enzymes in Italian populations.
Serpe L; Canaparo R; Scordo MG; Spina E
Drug Metab Pers Ther; 2015 Jun; 30(2):107-20. PubMed ID: 25527811
[TBL] [Abstract][Full Text] [Related]
14. [Interindividual differences in efficacy and toxicity induced by therapeutic drugs and xenobiotics in relation to genetic polymorphisms in xenobiotic metabolizing enzymes].
Ozawa S
Kokuritsu Iyakuhin Shokuhin Eisei Kenkyusho Hokoku; 1998; (116):69-81. PubMed ID: 10097514
[TBL] [Abstract][Full Text] [Related]
15. Reactions and enzymes in the metabolism of drugs and other xenobiotics.
Testa B; Pedretti A; Vistoli G
Drug Discov Today; 2012 Jun; 17(11-12):549-60. PubMed ID: 22305937
[TBL] [Abstract][Full Text] [Related]
16. Molecular mechanism of phase I and phase II drug-metabolizing enzymes: implications for detoxification.
Iyanagi T
Int Rev Cytol; 2007; 260():35-112. PubMed ID: 17482904
[TBL] [Abstract][Full Text] [Related]
17. Genetic basis of toxic reactions to drugs and chemicals.
Cascorbi I
Toxicol Lett; 2006 Mar; 162(1):16-28. PubMed ID: 16310984
[TBL] [Abstract][Full Text] [Related]
18. Biotransformation of PCBs in relation to phase I and II xenobiotic-metabolizing enzyme activities in ringed seals (Phoca hispida) from Svalbard and the Baltic Sea.
Routti H; Letcher RJ; Arukwe A; Van Bavel B; Yoccoz NG; Chu S; Gabrielsen GW
Environ Sci Technol; 2008 Dec; 42(23):8952-8. PubMed ID: 19192824
[TBL] [Abstract][Full Text] [Related]
19. Phase II enzymes and bioactivation.
Hinson JA; Forkert PG
Can J Physiol Pharmacol; 1995 Oct; 73(10):1407-13. PubMed ID: 8748931
[TBL] [Abstract][Full Text] [Related]
20. Cancer and molecular biomarkers of phase 2.
Dalhoff K; Buus Jensen K; Enghusen Poulsen H
Methods Enzymol; 2005; 400():618-27. PubMed ID: 16399374
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
